TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 171 filers reported holding TRAVERE THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $888,860 | -55.4% | 99,425 | +12.3% | 0.00% | -100.0% |
| Q2 2023 | $1,991,378 | 0.0% | 88,545 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,991,378 | +48.9% | 88,545 | +39.3% | 0.00% | 0.0% |
| Q4 2022 | $1,337,045 | -99.9% | 63,578 | +1.8% | 0.00% | 0.0% |
| Q3 2022 | $1,538,177,000 | -4.1% | 62,426 | -5.7% | 0.00% | 0.0% |
| Q2 2022 | $1,603,177,000 | -7.4% | 66,165 | -1.5% | 0.00% | 0.0% |
| Q1 2022 | $1,731,255,000 | -11.7% | 67,181 | +6.3% | 0.00% | 0.0% |
| Q4 2021 | $1,961,355,000 | +56.2% | 63,188 | +22.0% | 0.00% | 0.0% |
| Q3 2021 | $1,255,543,000 | +60.7% | 51,775 | -3.3% | 0.00% | – |
| Q2 2021 | $781,353,000 | -36.6% | 53,554 | +8.4% | 0.00% | -100.0% |
| Q1 2021 | $1,233,143,000 | +17.0% | 49,385 | +27.7% | 0.00% | – |
| Q4 2020 | $1,054,359,000 | – | 38,685 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MASSMUTUAL TRUST CO FSB/ADV | 235 | $2,113 | 0.00% |